Concepedia
Statistics
Publications
11
Citations
735
H-Index
Active since
2013
Affiliations
Roche (Switzerland)(Current)
Roche Pharma AG (Germany)
RWTH Aachen University
University of Basel
Center for Integrated Protein Science Munich
Carina Hage is an author at Roche (Switzerland) specializing in oncology, immunology, and life sciences.
Publications per year
2013–2024
Sorafenib Induces Pyroptosis in Macrophages and Triggers Natural Killer Cell–Mediated Cytotoxicity Against Hepatocellular Carcinoma
Carina Hage, Sabine Hoves, Léanne Strauss et al. · Hepatology · 2019 · 237 citations
Life Sciences, Immunology, Pharmacology +17
The novel c-Met inhibitor cabozantinib overcomes gemcitabine resistance and stem cell signaling in pancreatic cancer
Carina Hage, Vanessa Rausch, Nathalia A. Giese et al. · Cell Death and Disease · 2013 · 117 citations · Full text
Medicine, Oncology, Pharmacology +17
Protease-activation using anti-idiotypic masks enables tumor specificity of a folate receptor 1-T cell bispecific antibody
Martina Geiger, Kay‐Gunnar Stubenrauch, Johannes Sam et al. · Nature Communications · 2020 · 91 citations · Full text
Medicine, Cancer Biology, Oncology +17
Human immunocompetent Organ-on-Chip platforms allow safety profiling of tumor-targeted T-cell bispecific antibodies
S. Jordan Kerns, Chaitra Belgur, Debora B. Petropolis et al. · eLife · 2021 · 75 citations · Full text
Life Sciences, Immunology, Oncology +15
Macrophage depletion induces edema through release of matrix-degrading proteases and proteoglycan deposition
Stefan Bissinger, Carina Hage, Vinona Wagner et al. · Science Translational Medicine · 2021 · 58 citations · Full text
Life Sciences, Cell Biology, Immunology +17
1–5 of 11